Oxford immunologist on coronavirus vaccine: our early results look highly promising
A vaccine against Covid-19 is urgently needed if we’re to stop the novel coronavirus spreading and prevent potentially millions of further deaths. We’re now one step closer to that goal.
We have published early results (https://www.ovg.ox.ac.uk/news/new-study-reveals-oxford-coronavirus-vaccine-produces-strong-immune-response) from our clinical trial of the vaccine ChAdOx1 nCoV-19 (also known as AZD1222), designed by the University of Oxford and developed in partnership with AstraZeneca. The preliminary data shows that it is safe and induced a strong antibody response in all vaccinated volunteers, suggesting that an effective vaccine could be within reach...
Would you like to comment on this article?
Sign up (it's quick and free) or sign in now.
Please read our Comment Policy before commenting.
Subscribe now to unlock this article.
Support BusinessLIVE’s award-winning journalism for R129 per month (digital access only).
There’s never been a more important time to support independent journalism in SA. Our subscription packages now offer an ad-free experience for readers.
Cancel anytime.
Questions? Email helpdesk@businesslive.co.za or call 0860 52 52 00. Got a subscription voucher? Redeem it now.